These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1874 related articles for article (PubMed ID: 32829453)

  • 1. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression.
    Das TK; Ganesh BP
    Gut Microbes; 2023; 15(1):2206504. PubMed ID: 37127846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
    De la Fuente M
    J Alzheimers Dis; 2021; 81(4):1345-1360. PubMed ID: 33935086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila.
    Wu SC; Cao ZS; Chang KM; Juang JL
    Nat Commun; 2017 Jun; 8(1):24. PubMed ID: 28634323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
    Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential.
    Qu L; Li Y; Liu F; Fang Y; He J; Ma J; Xu T; Wang L; Lei P; Dong H; Jin L; Yang Q; Wu W; Sun D
    Aging Dis; 2024 May; 15(3):1108-1131. PubMed ID: 37728579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease.
    Bonfili L; Cecarini V; Gogoi O; Gong C; Cuccioloni M; Angeletti M; Rossi G; Eleuteri AM
    FEBS J; 2021 May; 288(9):2836-2855. PubMed ID: 32969566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMN synbiotics intervention modulates gut microbiota and metabolism in APP/PS1 Alzheimer's disease mouse models.
    Zhang J; Zhao X; Xu H; Liu X; He Y; Tan X; Gu J
    Biochem Biophys Res Commun; 2024 Sep; 726():150274. PubMed ID: 38924882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome in Alzheimer's Disease: from Mice to Humans.
    Liang C; Pereira R; Zhang Y; Rojas OL
    Curr Neuropharmacol; 2024; 22(14):2314-2329. PubMed ID: 39403057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics, gut microbiota, and Alzheimer's disease.
    Angelucci F; Cechova K; Amlerova J; Hort J
    J Neuroinflammation; 2019 May; 16(1):108. PubMed ID: 31118068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.